Homecoming congress recognises esophagus expertise in Tokyo
The World Congress for Esophageal Diseases is expected to be bigger than ever when it returns in Tokyo in 2022, in recognition of the important role that Japan plays in research and treatment of the esophagus.
The event is a homecoming for the city: the International Society for Diseases of the Esophagus (ISDE) was founded by Dr Kōmei Nakayama in 1979 and the first ISDE World Congress was held in Tokyo in 1980. The event aims to promote the exchange of scientific and medical knowledge among specialists in fields related to the esophagus.
ISDE President Prateek Sharma said: “Japan is known for their cutting-edge treatments in the field of endoscopy and surgical procedures. This is a great opportunity for members and attendees from around the world and from Japan to observe, learn and share information on the esophagus.”
Japan is known for its innovation in the medical sector, with Tokyo, particularly the area around Nihonbashi, a growing hub of life sciences and drug discovery activity.
The ISDE 2022 World Congress is expected to attract 1,100 delegates from more than 40 countries, and take place September 26-28, 2022 at the Keio Plaza Hotel.
The event will be co-hosted by the Japan Esophageal Society, which will also hold its JES Annual Meeting just prior to the World Congress at the same venue. The JES currently has over 2,000 members of which about 1,200 usually attend the Annual Meeting. The congress is being framed as a perfect opportunity for medical professionals in Japan to stay on and study the latest trends in the field as well as communicate with professionals from around the world.
ISDE Executive Director, Mark Ferguson said: “The 2022 Congress in Tokyo, Japan marks the 4th time this meeting has been held in this country and honors a longstanding relationship between ISDE and the Japanese Esophageal Society (JES). We anticipate this meeting will have the highest attendance numbers of any of our congresses to date.”
The immediate past President of ISDE, Dr Yuko Kitagawa, is based in Tokyo, where he is a surgical oncologist and clinical and translational researcher, mainly in the areas of gastrointestinal cancers. He is a chair of the Japan Esophageal Oncology Group, and a Professor at Keio University. He is working as a principal investigator for several important nation-wide clinical studies including sentinel node mapping for gastric cancer and multimodal treatment for esophageal cancer.
Published Date: 25/07/2019